- Home
- DVA vs CLS Comparison
DVA vs CLS Comparison
Compare DVA & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- CLS
- Stock Information
- Founded
- DVA 1994
- CLS 1994
- Country
- DVA United States
- CLS Canada
- Employees
- DVA N/A
- CLS N/A
- Industry
- DVA Misc Health and Biotechnology Services
- CLS Electrical Products
- Sector
- DVA Health Care
- CLS Technology
- Exchange
- DVA Nasdaq
- CLS Nasdaq
- Market Cap
- DVA 9.7B
- CLS 9.7B
- IPO Year
- DVA 1995
- CLS 1998
- Fundamental
- Price
- DVA $130.10
- CLS $254.42
- Analyst Decision
- DVA Hold
- CLS Strong Buy
- Analyst Count
- DVA 3
- CLS 10
- Target Price
- DVA $154.67
- CLS $190.70
- AVG Volume (30 Days)
- DVA 663.6K
- CLS 3.2M
- Earning Date
- DVA 10-28-2025
- CLS 10-27-2025
- Dividend Yield
- DVA N/A
- CLS N/A
- EPS Growth
- DVA 8.72
- CLS 55.91
- EPS
- DVA 10.20
- CLS 4.59
- Revenue
- DVA $13,161,328,000.00
- CLS $10,587,200,000.00
- Revenue This Year
- DVA $5.96
- CLS $20.66
- Revenue Next Year
- DVA $3.54
- CLS $17.22
- P/E Ratio
- DVA $12.76
- CLS $53.07
- Revenue Growth
- DVA 5.09
- CLS 20.52
- 52 Week Low
- DVA $126.07
- CLS $44.46
- 52 Week High
- DVA $179.60
- CLS $258.16
- Technical
- Relative Strength Index (RSI)
- DVA 38.72
- CLS 70.89
- Support Level
- DVA $131.77
- CLS $237.73
- Resistance Level
- DVA $137.58
- CLS $254.00
- Average True Range (ATR)
- DVA 2.61
- CLS 12.46
- MACD
- DVA -0.54
- CLS 2.78
- Stochastic Oscillator
- DVA 4.45
- CLS 94.99
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.